Part D vs. Obamacare Roll-Out: The Comparisons Continue
This article was originally published in RPM Report
The Part D rollout is not a perfect parallel for the launch of the Affordable Care Act, but comparing their respective “glitches” is now commonplace. Former CMS Administrator Mark McClellan sees important differences—and cautions that the toughest test is still to come.
You may also be interested in...
Initial confusion on access, eligibility and paperwork greeted the rollout of phased national health insurance for Indonesia that aims to achieve a nationwide footprint before the end of the decade.
In the run up to its launch in 2006, Part D was politically controversial and there was considerable skepticism about the logistical challenges for implementation. That experience is reassuring for implementers of the Affordable Care Act – but advocates should be wary of relying too much on parallels to Part D.
US biopharma companies are warning of significant changes in drug development priorities as they prepare for the implementation of new Medicare pricing measures enacted in 2022. Those changes will have ripple effects on the FDA, which may spark some responses.